| Total Patient |
FT Baseline |
FT 1 –week |
CFT Baseline |
CFT 1-week |
| Bromfenac (N
= 88) |
206.65 ±
16.38 |
220.58 ±
22.21 |
174.44 ± 8.99 |
184.86 ±
12.28 |
| Nepafenac (N
= 85) |
207.84 ±
12.88 |
222.84 ±
22.03 |
176.68 ±
11.31 |
187.79 ±
15.29 |
| P < 0.05 |
P = 0.30 |
P = 0.25 |
P = 0.07 |
p = 0.08 |
| |
|
|
|
|
| Diabetic |
FT Baseline |
FT 1 –week |
CFT Baseline |
CFT 1-week |
| Bromfenac (N
= 29) |
218.03 ±
20.18 |
226.86 ±
22.02 |
175.41 ± 7.89 |
182.38 ±
10.05 |
| Nepafenac (N
= 30) |
214.27 ±
12.35 |
225.30 ±
16.03 |
178.57 ±
13.49 |
186.70 ±
13.60 |
| P < 0.05 |
P = 0.19 |
P = 0.38 |
P = 0.14 |
P = 0.085 |
FT = foveal thickness in micrometer: rhe mean thickness within the central 1000
micron diameter area of the fovea4 CFT = central foveal thickness in micrometer: the mean thickness easured 01 the
poim of intersection o/the si.x radial scans by OCT4 |
